Joshua H. Bilenker - Net Worth and Insider Trading

Joshua H. Bilenker Net Worth

The estimated net worth of Joshua H. Bilenker is at least $46 Million dollars as of 2024-12-26. Joshua H. Bilenker is the President & CEO of Loxo Oncology Inc and owns about 194,407 shares of Loxo Oncology Inc (LOXO) stock worth over $46 Million. Joshua H. Bilenker is also the Director of Sana Biotechnology Inc and owns about 20,000 shares of Sana Biotechnology Inc (SANA) stock worth over $34,900. Details can be seen in Joshua H. Bilenker's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joshua H. Bilenker has not made any transactions after 2021-02-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Joshua H. Bilenker

To

Joshua H. Bilenker Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joshua H. Bilenker owns 6 companies in total, including Gossamer Bio Inc (GOSS) , Loxo Oncology Inc (LOXO) , and ViewRay Inc (VRAYQ) among others .

Click here to see the complete history of Joshua H. Bilenker’s form 4 insider trades.

Insider Ownership Summary of Joshua H. Bilenker

Ticker Comapny Transaction Date Type of Owner
GOSS Gossamer Bio Inc 2019-02-07 director
LOXO Loxo Oncology Inc 2019-02-15 director & President & CEO
VRAYQ ViewRay Inc 2016-03-30 director & 10 percent owner
LIMIT LIMIT 2014-08-06 director
LIMIT LIMIT 2014-07-16 director
LIMIT LIMIT 2021-02-03 director

Joshua H. Bilenker Latest Holdings Summary

Joshua H. Bilenker currently owns a total of 2 stocks. Among these stocks, Joshua H. Bilenker owns 194,407 shares of Loxo Oncology Inc (LOXO) as of December 11, 2018, with a value of $46 Million and a weighting of 99.92%. Joshua H. Bilenker also owns 20,000 shares of Sana Biotechnology Inc (SANA) as of February 3, 2021, with a value of $34,900 and a weighting of 0.08%.

Latest Holdings of Joshua H. Bilenker

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LOXO Loxo Oncology Inc 2018-12-11 194,407 234.66 45,619,547
SANA Sana Biotechnology Inc 2021-02-03 20,000 1.75 34,900

Holding Weightings of Joshua H. Bilenker


Joshua H. Bilenker Form 4 Trading Tracker

According to the SEC Form 4 filings, Joshua H. Bilenker has made a total of 0 transactions in Loxo Oncology Inc (LOXO) over the past 5 years. The most-recent trade in Loxo Oncology Inc is the sale of 20,000 shares on December 11, 2018, which brought Joshua H. Bilenker around $3 Million.

According to the SEC Form 4 filings, Joshua H. Bilenker has made a total of 1 transactions in Sana Biotechnology Inc (SANA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sana Biotechnology Inc is the acquisition of 20,000 shares on February 3, 2021, which cost Joshua H. Bilenker around $500,000.

Insider Trading History of Joshua H. Bilenker

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joshua H. Bilenker Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joshua H. Bilenker Ownership Network

Ownership Network List of Joshua H. Bilenker

No Data

Ownership Network Relation of Joshua H. Bilenker

Insider Network Chart

Joshua H. Bilenker Owned Company Details

What does Gossamer Bio Inc do?

Who are the key executives at Gossamer Bio Inc?

Joshua H. Bilenker is the director of Gossamer Bio Inc. Other key executives at Gossamer Bio Inc include Chief Medical Officer Richard Aranda , director & Executive Chairman Faheem Hasnain , and Chief Financial Officer Bryan Giraudo .

Gossamer Bio Inc (GOSS) Insider Trades Summary

Over the past 18 months, Joshua H. Bilenker made no insider transaction in Gossamer Bio Inc (GOSS). Other recent insider transactions involving Gossamer Bio Inc (GOSS) include a net purchase of 293,570 shares made by Bryan Giraudo , a net purchase of 348,828 shares made by Faheem Hasnain , and a net sale of 5,926 shares made by Richard Aranda .

In summary, during the past 3 months, insiders sold 0 shares of Gossamer Bio Inc (GOSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,976 shares of Gossamer Bio Inc (GOSS) were sold and 729,000 shares were bought by its insiders, resulting in a net purchase of 683,024 shares.

Gossamer Bio Inc (GOSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Gossamer Bio Inc Insider Transactions

No Available Data

Joshua H. Bilenker Mailing Address

Above is the net worth, insider trading, and ownership report for Joshua H. Bilenker. You might contact Joshua H. Bilenker via mailing address: C/o Loxo Oncology, Inc., One Landmark Square, Suite 1122, Stamford Ct 06901.

Discussions on Joshua H. Bilenker

No discussions yet.